Mitochondriale Zytopathien

Literatur

• 1 Anderson S, Bankier A T, Barrell B G. et al . Sequence and organization of the human mitochondrial genome.  Nature. 1981;  290 457-465
• 2 Argov Z, Bank W J. Phosphorus magnetic resonance spectroscopy (31P-MRS) in neuromuscular disorders.  Ann Neurol. 1991;  30 90-97
• 3 Bourgeron T, Chretien D, Amati P. et al . Expression of respiratory chain deficiencies in human cultured cells.  Neuromuscul Disord. 1993;  3 605-608
• 4 Chan A, Reichmann H, Kogel A. et al . Metabolic changes in patients with mitochondrial myopathies and effects of coenzyme Q10 therapy.  J Neurol. 1998;  245 681-685
• 5 DeVivo D C, Hirano M, DiMauro S. Mitochondrial disorders. Amsterdam:Elsevier In:Vinken PJ, Bruyn GW, editors. Neurodystrophies and Neurolipidoses 1996: 389-446
• 6 DiDonato S. Diseases associated with defects of beta-oxidation. Boston: Butterworth-Heinemann Rosenberg RN, Prusiner SB, DiMauro S, Barchi RL, editors. The Molecular and Genetic Basis of Neurological Disease 1997: 939-956
• 7 Gerbitz K D, Gempel K, Brdiczka D. Mitochondria and diabetes. Genetic, biochemical and clinical implications of the cellular energy circuit.  Diabetes. 1996;  45 113-126
• 8 Loeffen J, Smeitink J, Triepels R. et al . The first nuclear-encoded complex I mutation in a patient with Leigh syndrome.  Am J Hum Genet. 1998;  63 1598-1608
• 9 Pons R, Andreetta F, Wang C H. et al . Mitochondrial myopathy simulating spinal muscular atrophy.  Pediatr Neurol. 1996;  15 153-158
• 10 Rahman S, Lake B D, Taanman J W. et al . Cytochrome oxidase immunohistochemistry: clues for genetic mechanisms.  Brain. 2000;  123 591-600
• 11 Tiranti V, Hoertnagel K, Carrozzo R. et al . Mutations of SURF-1 in Leigh disease associated with cytochrome c oxidase deficiency.  Am J Hum Genet. 1998;  63 1609-1621
• 12 Walker U A. Mitochondriale Medizin: Das 25. Chromosom und mitochondriale Erkrankungen.  Dtsch Med Wschr. 1999;  124 189-192

Korrespondenz